- Dual-action glucose-lowering effect targeting both liver glucose output and pancreatic insulin response.
- Significant reduction in HbA1c levels, aiding in achieving target glycaemic goals.
- Lower risk of hypoglycaemia compared to other diabetes medications like sulfonylureas.
- Weight-neutral profile with minimal risk of weight gain associated with Sitara M 50/500 mg Tablet.
- Favorable safety record with good tolerability in most patients using Sitara M 50/500 mg Tablet.
- Simplified treatment regimen through a single combination tablet, available in both immediate-release and extended-release formulations.
- Helps manage both fasting and postprandial blood glucose levels effectively.
- Reduces the risk of long-term complications related to type 2 diabetes, including cardiovascular issues and neuropathy.
Sitara M 50/500 mg Tablet - Strip of 10
Compositions : Metformin 500mg + Sitagliptin 50mg
MRP :
MRP :
Out of stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Intas Pharmaceuticals Ltd.
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Sitara M 50/500 mg Tablet is a prescription medication specifically designed to aid in the management of blood sugar levels in adults diagnosed with type 2 diabetes mellitus. This innovative formulation combines two active ingredients, Metformin and Sitagliptin, which work synergistically to enhance glucose regulation. Metformin, a member of the biguanide class, functions by decreasing glucose production in the liver, improving insulin sensitivity, and slowing the absorption of sugar from food in the intestines. On the other hand, Sitagliptin is classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which elevates the levels of natural incretin hormones. These hormones play a crucial role in stimulating the pancreas to release more insulin post-meals while simultaneously reducing hepatic glucose production. The dual-action mechanism of Sitara M 50/500 mg Tablet makes it an effective choice for patients whose blood sugar levels remain uncontrolled despite dietary modifications and exercise. By utilizing both Metformin and Sitagliptin, Sitara M 50/500 mg Tablet not only helps lower blood sugar levels throughout the day but also minimizes the risk of long-term complications associated with type 2 diabetes, such as cardiovascular diseases, chronic kidney disease, and diabetic neuropathy. Regular monitoring of blood sugar levels and kidney function is recommended during treatment with Sitara M 50/500 mg Tablet to ensure optimal therapeutic outcomes. Your healthcare provider will determine the most suitable dosage and formulation tailored to your specific condition, ensuring that you achieve effective blood sugar control with Sitara M 50/500 mg Tablet.
Product Details
Sitara M 50/500 mg Tablet operates through a combination of two active ingredients: Metformin and Sitagliptin. Metformin reduces glucose production in the liver and enhances insulin sensitivity, while Sitagliptin promotes increased insulin secretion from the pancreas. Together, these components provide comprehensive control over blood sugar levels.
- Administer Sitara M 50/500 mg Tablet exactly as prescribed by your healthcare provider.
- Take the tablet with meals to minimize gastrointestinal discomfort.
- Typically taken once or twice daily based on your doctor's recommendations.
- Swallow extended-release tablets whole; do not crush or chew them.
- Maintain a consistent schedule by taking Sitara M 50/500 mg Tablet at the same time each day.
- Regularly monitor your blood sugar levels as directed by your healthcare professional.
- Avoid discontinuing Sitara M 50/500 mg Tablet without consulting your doctor first.
- Consult your doctor for personalized dosage recommendations based on your health status.
- Incorporate regular physical activity into your daily routine to enhance the effectiveness of Sitara M 50/500 mg Tablet.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while monitoring carbohydrate intake.
- Avoid excessive consumption of high-fat meals that may exacerbate gastrointestinal side effects associated with Sitara M 50/500 mg Tablet.
- Carry a source of fast-acting sugar for emergencies in case of hypoglycemia while on this medication.
- Regularly check your feet for any sores or infections as part of diabetes management while using Sitara M 50/500 mg Tablet.
- Ensure annual kidney function tests are conducted to monitor health while taking Sitara M 50/500 mg Tablet.
Safety Advice
Side Effects
- Common side effects include nausea, diarrhea, and stomach upset, particularly during initial treatment with Sitara M 50/500 mg Tablet.
- Mild headaches may occur as your body adjusts to the medication.
- Cold-like symptoms such as a runny nose or sore throat may be experienced by some users.
- Uncommon side effects may include skin rash, joint pain, changes in taste, or mild swelling of extremities.
- Serious side effects requiring immediate medical attention include lactic acidosis, characterized by severe fatigue, muscle pain, or difficulty breathing.
- Pancreatitis symptoms such as severe abdominal pain radiating to the back should prompt urgent medical consultation.
- Monitor for rare elevations in liver enzymes that may necessitate further evaluation.
- Seek immediate help for severe allergic reactions manifesting as swelling of the face or difficulty breathing while using Sitara M 50/500 mg Tablet.
Precautions and Warnings
- Avoid using Sitara M 50/500 mg Tablet if you have known allergies to its components or severe kidney/liver impairment.
- Consult your doctor before using this medication if you are pregnant or breastfeeding.
- Limit alcohol consumption while taking Sitara M 50/500 mg Tablet due to increased risk of lactic acidosis.
- Regular kidney function monitoring is essential during treatment with Sitara M 50/500 mg Tablet.
- Be cautious when driving or operating machinery if experiencing low blood sugar episodes while on this medication.
- Inform your healthcare provider about any other medications you are taking to avoid potential interactions with Sitara M 50/500 mg Tablet.
- If you have a history of heart failure or pancreatic disease, discuss the use of Sitara M 50/500 mg Tablet with your doctor for tailored advice.
FAQs
Sitara M 50/500 mg Tablet is utilized for enhancing blood sugar control in adults with type 2 diabetes. It is prescribed when lifestyle changes or single-agent therapies are insufficient.
2. How does Sitara M 50/500 mg Tablet work?
The medication aids in effective insulin utilization and reduces excess glucose production by the liver, thus improving overall blood sugar management.
3. When should I take Sitara M 50/500 mg Tablet?
It is generally recommended to take this tablet with meals to minimize stomach upset. The specific timing may vary based on whether you are using an immediate or extended-release form.
4. How long does it take for Sitara M 50/500 mg Tablet to lower blood sugar?
Initial improvements may be observed within days; however, significant benefits typically manifest over several weeks with consistent use.
5. Can I drink alcohol while taking Sitara M 50/500 mg Tablet?
It is advisable to limit alcohol intake while on this medication due to potential risks associated with lactic acidosis.
6. Is it safe for long-term use?
Yes, Sitara M 50/500 mg Tablet can be safely used long-term under medical supervision with regular monitoring of blood sugar and kidney function.
7. What should I do if I miss a dose?
If you forget a dose, take it as soon as you remember unless it's close to your next scheduled dose. In that case, skip the missed dose.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 162263 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Sitara M 50/500 mg Tablet is a prescription medication specifically designed to aid in the management of blood sugar levels in adults diagnosed with type 2 diabetes mellitus. This innovative formulation combines two active ingredients, Metformin and Sitagliptin, which work synergistically to enhance glucose regulation. Metformin, a member of the biguanide class, functions by decreasing glucose production in the liver, improving insulin sensitivity, and slowing the absorption of sugar from food in the intestines. On the other hand, Sitagliptin is classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which elevates the levels of natural incretin hormones. These hormones play a crucial role in stimulating the pancreas to release more insulin post-meals while simultaneously reducing hepatic glucose production. The dual-action mechanism of Sitara M 50/500 mg Tablet makes it an effective choice for patients whose blood sugar levels remain uncontrolled despite dietary modifications and exercise. By utilizing both Metformin and Sitagliptin, Sitara M 50/500 mg Tablet not only helps lower blood sugar levels throughout the day but also minimizes the risk of long-term complications associated with type 2 diabetes, such as cardiovascular diseases, chronic kidney disease, and diabetic neuropathy. Regular monitoring of blood sugar levels and kidney function is recommended during treatment with Sitara M 50/500 mg Tablet to ensure optimal therapeutic outcomes. Your healthcare provider will determine the most suitable dosage and formulation tailored to your specific condition, ensuring that you achieve effective blood sugar control with Sitara M 50/500 mg Tablet.
- Dual-action glucose-lowering effect targeting both liver glucose output and pancreatic insulin response.
- Significant reduction in HbA1c levels, aiding in achieving target glycaemic goals.
- Lower risk of hypoglycaemia compared to other diabetes medications like sulfonylureas.
- Weight-neutral profile with minimal risk of weight gain associated with Sitara M 50/500 mg Tablet.
- Favorable safety record with good tolerability in most patients using Sitara M 50/500 mg Tablet.
- Simplified treatment regimen through a single combination tablet, available in both immediate-release and extended-release formulations.
- Helps manage both fasting and postprandial blood glucose levels effectively.
- Reduces the risk of long-term complications related to type 2 diabetes, including cardiovascular issues and neuropathy.
Sitara M 50/500 mg Tablet operates through a combination of two active ingredients: Metformin and Sitagliptin. Metformin reduces glucose production in the liver and enhances insulin sensitivity, while Sitagliptin promotes increased insulin secretion from the pancreas. Together, these components provide comprehensive control over blood sugar levels.
- Administer Sitara M 50/500 mg Tablet exactly as prescribed by your healthcare provider.
- Take the tablet with meals to minimize gastrointestinal discomfort.
- Typically taken once or twice daily based on your doctor's recommendations.
- Swallow extended-release tablets whole; do not crush or chew them.
- Maintain a consistent schedule by taking Sitara M 50/500 mg Tablet at the same time each day.
- Regularly monitor your blood sugar levels as directed by your healthcare professional.
- Avoid discontinuing Sitara M 50/500 mg Tablet without consulting your doctor first.
- Consult your doctor for personalized dosage recommendations based on your health status.
- Incorporate regular physical activity into your daily routine to enhance the effectiveness of Sitara M 50/500 mg Tablet.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while monitoring carbohydrate intake.
- Avoid excessive consumption of high-fat meals that may exacerbate gastrointestinal side effects associated with Sitara M 50/500 mg Tablet.
- Carry a source of fast-acting sugar for emergencies in case of hypoglycemia while on this medication.
- Regularly check your feet for any sores or infections as part of diabetes management while using Sitara M 50/500 mg Tablet.
- Ensure annual kidney function tests are conducted to monitor health while taking Sitara M 50/500 mg Tablet.
Side Effects
- Common side effects include nausea, diarrhea, and stomach upset, particularly during initial treatment with Sitara M 50/500 mg Tablet.
- Mild headaches may occur as your body adjusts to the medication.
- Cold-like symptoms such as a runny nose or sore throat may be experienced by some users.
- Uncommon side effects may include skin rash, joint pain, changes in taste, or mild swelling of extremities.
- Serious side effects requiring immediate medical attention include lactic acidosis, characterized by severe fatigue, muscle pain, or difficulty breathing.
- Pancreatitis symptoms such as severe abdominal pain radiating to the back should prompt urgent medical consultation.
- Monitor for rare elevations in liver enzymes that may necessitate further evaluation.
- Seek immediate help for severe allergic reactions manifesting as swelling of the face or difficulty breathing while using Sitara M 50/500 mg Tablet.
Precautions and Warnings
- Avoid using Sitara M 50/500 mg Tablet if you have known allergies to its components or severe kidney/liver impairment.
- Consult your doctor before using this medication if you are pregnant or breastfeeding.
- Limit alcohol consumption while taking Sitara M 50/500 mg Tablet due to increased risk of lactic acidosis.
- Regular kidney function monitoring is essential during treatment with Sitara M 50/500 mg Tablet.
- Be cautious when driving or operating machinery if experiencing low blood sugar episodes while on this medication.
- Inform your healthcare provider about any other medications you are taking to avoid potential interactions with Sitara M 50/500 mg Tablet.
- If you have a history of heart failure or pancreatic disease, discuss the use of Sitara M 50/500 mg Tablet with your doctor for tailored advice.
Sitara M 50/500 mg Tablet is utilized for enhancing blood sugar control in adults with type 2 diabetes. It is prescribed when lifestyle changes or single-agent therapies are insufficient.
2. How does Sitara M 50/500 mg Tablet work?
The medication aids in effective insulin utilization and reduces excess glucose production by the liver, thus improving overall blood sugar management.
3. When should I take Sitara M 50/500 mg Tablet?
It is generally recommended to take this tablet with meals to minimize stomach upset. The specific timing may vary based on whether you are using an immediate or extended-release form.
4. How long does it take for Sitara M 50/500 mg Tablet to lower blood sugar?
Initial improvements may be observed within days; however, significant benefits typically manifest over several weeks with consistent use.
5. Can I drink alcohol while taking Sitara M 50/500 mg Tablet?
It is advisable to limit alcohol intake while on this medication due to potential risks associated with lactic acidosis.
6. Is it safe for long-term use?
Yes, Sitara M 50/500 mg Tablet can be safely used long-term under medical supervision with regular monitoring of blood sugar and kidney function.
7. What should I do if I miss a dose?
If you forget a dose, take it as soon as you remember unless it's close to your next scheduled dose. In that case, skip the missed dose.
Directions for Use
Storage and Disposal
| SKU | 162263 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account